Related Experiment Videos
Huntington disease: a detective story
1University of Oklahoma College of Medicine-Tulsa.
Insights
Recombinant DNA diagnostics significantly improve genetic risk assessment for inherited diseases like Huntington disease. This advanced genetic analysis provides more accurate risk figures, even when family history is limited.
Area of Science:
- Medical Genetics
- Molecular Diagnostics
Background:
- Recombinant DNA diagnostics are becoming standard for inherited diseases.
- Physicians need to identify and counsel at-risk families.
- Obtaining accurate risk figures can be challenging with incomplete family histories.
Purpose of the Study:
- To illustrate the application of recombinant DNA analysis in a complex genetic risk assessment scenario.
- To demonstrate the utility of advanced genetic techniques when traditional methods are insufficient.
Main Methods:
- Extensive family history collection.
- Identification and ordering of informative genetic markers around the disease gene.
- Application of statistical analyses for risk calculation.
- Recombinant DNA analysis for precise genetic diagnosis.
Main Results:
- Achieved a reduced risk estimate of less than 1% for Huntington disease in a patient with an apparent 50% risk.
- Successfully overcame limitations posed by deceased affected relatives and incomplete family history.
Conclusions:
- Recombinant DNA techniques offer powerful capabilities for diagnosing genetic disorders.
- These methods are crucial for improving genetic risk assessment accuracy for practicing physicians.
- Advanced genetic analysis enhances patient counseling and management for inherited diseases.
Abstract:
As recombinant DNA diagnoses of various inherited diseases become a standard medical procedure, the practicing physician will be required to identify families at risk and counsel them (or refer them) appropriately. In many families the risk may not be immediately obvious or a reliable risk figure may appear to be unattainable. In the case presented, the patient had an apparent 50% risk for Huntington disease and all the immediate affected relatives were deceased. This relatively common scenario would generally prevent recombinant DNA diagnostic procedures from arriving at a more accurate risk estimate. Nevertheless, by recombinant DNA analysis, a risk for Huntington disease of less than 1% was obtained. Several key aspects of genetic analysis were required including extensive family histories, identification of informative markers, ordering the markers around the disease gene and appropriate statistical analyses. These discussions illustrate the power of recombinant DNA techniques to detect genetic disorders and demonstrate why they will be of increasing importance to the practicing physician.